Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Magnetic brain stimulation plus mirror therapy for hemispatial neglect

Official title: Evaluation of the Effectiveness of Transcranial Magnetic Stimulation and Mirror Therapy in Hemispatial Neglect Developing After Stroke

Run by Ankara Etlik City Hospital · NCT07228871 · Data updated 2026-11-12

We will test whether adding continuous theta burst magnetic stimulation to mirror therapy helps people with hemispatial neglect after a right-sided stroke.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment22 (estimated)
SponsorAnkara Etlik City Hospital
Government
Locations1 site (Ankara, Yenimahalle)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedJanuary 31, 2027
Study endsJanuary 31, 2027
Registry record updatedFebruary 24, 2026
Trial IDNCT07228871 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–75 with a first right-hemisphere ischemic or hemorrhagic stroke occurring 7 days to 1 year earlier who have hemispatial neglect and an MMSE score of 24 or higher.

Probably not a fit

Patients with recurrent stroke, epilepsy, metallic brain or scalp implants, significant vision or hearing problems, premorbid dementia, psychiatric or other neurological disease, or use of cognition-affecting medications are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with hemispatial neglect due to a right-hemisphere ischemic or hemorrhagic stroke will be enrolled at Ankara Etlik City Hospital. Participants receive mirror therapy combined with continuous theta burst stimulation (cTBS) alongside standard cognitive rehabilitation according to the study protocol. Outcomes focus on changes in neglect severity and attention-related function over the treatment and follow-up period. Common exclusions include recurrent stroke, seizures, metal implants, significant sensory deficits, cognitive impairment, psychiatric or other neurologic disease.

Why it matters

Potential benefit: If successful, the combined treatment could reduce neglect symptoms and improve patients' ability to attend to the affected side in daily life.

How similar studies have gone: Previous trials using rTMS or mirror therapy alone have shown modest improvements in neglect, but combining cTBS with mirror therapy is less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Ischemic/haemorrhagic stroke
2. Right hemisphere lesion
3. Patients with a duration of more than 7 days but less than 1 year from the date of the event
4. Aged between 18 and 75 years
5. Patients with a Mini Mental Test Score ≥ 24

Exclusion Criteria:

1. History of recurrent stroke
2. Presence of vision or hearing problems
3. Use of medication affecting cognitive function
4. History of epilepsy
5. Pregnancy or breastfeeding
6. History of malignancy
7. Pacemaker
8. Presence of metallic implants in the brain or scalp (including cochlear implant)
9. History of premorbid dementia
10. Presence of psychiatric or additional neurological disease

Where it's running

  • Ankara Etlik City Hospital
    Ankara, Yenimahalle, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.